Order Article Reprints

Laios A, Mohamed BM, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Sheils O, Ring M, et al. Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening. International Journal of Molecular Sciences. 2013; 14(1):2085-2103. https://doi.org/10.3390/ijms14012085

Laios, Alexandros, Bashir M. Mohamed, Lynne Kelly, Richard Flavin, Stephen Finn, Lynda McEvoy, Michael Gallagher, Cara Martin, Orla Sheils, Martina Ring, and et al. 2013. "Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening" International Journal of Molecular Sciences 14, no. 1: 2085-2103. https://doi.org/10.3390/ijms14012085

Laios, A., Mohamed, B. M., Kelly, L., Flavin, R., Finn, S., McEvoy, L., Gallagher, M., Martin, C., Sheils, O., Ring, M., Davies, A., Lawson, M., Gleeson, N., D'Arcy, T., D'Adhemar, C., Norris, L., Langhe, R., Saadeh, F. A., O'Leary, J. J., & O'Toole, S. A. (2013). Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening. International Journal of Molecular Sciences, 14(1), 2085-2103. https://doi.org/10.3390/ijms14012085